(NYSE: ALC) Alcon's forecast annual revenue growth rate of 7.45% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.76%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.49%.
Alcon's revenue in 2026 is $10,185,000,000.On average, 26 Wall Street analysts forecast ALC's revenue for 2026 to be $5,521,579,200,000, with the lowest ALC revenue forecast at $5,265,664,000,000, and the highest ALC revenue forecast at $5,897,347,200,000. On average, 22 Wall Street analysts forecast ALC's revenue for 2027 to be $5,884,084,800,000, with the lowest ALC revenue forecast at $5,572,664,000,000, and the highest ALC revenue forecast at $6,252,484,800,000.
In 2028, ALC is forecast to generate $6,183,716,800,000 in revenue, with the lowest revenue forecast at $5,849,209,600,000 and the highest revenue forecast at $6,554,572,800,000.